ClinConnect ClinConnect Logo
Search / Trial NCT03934957

Hamburg City Health Study - a German Cohort Study

Launched by UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF · Apr 28, 2019

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Epidemiology Prospective Cohort Study Nutrition Prevention Psychiatric And Psychosomatic Disorders

ClinConnect Summary

The Hamburg City Health Study is a large research project that aims to learn more about various health conditions, such as heart disease, stroke, and cancer. Researchers are looking for factors that can help predict these diseases and understand how they affect people's lives over time. This study is open to residents of Hamburg who are between 45 and 74 years old and can speak German well enough to understand the study materials and participate in interviews.

Participants will be asked to provide their written consent to join the study and will then take part in different health assessments at a study center. This is a great opportunity to contribute to important health research that could benefit many people in the future. If you or someone you know meets the age and residency requirements and is interested in helping advance our understanding of chronic diseases, this study may be a good fit!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inhabitant of the city of Hamburg at the time of inclusion into the study (Inclusion is time of written consent)
  • Age 45 to 74 years
  • Personally signed informed consent
  • Exclusion Criteria:
  • Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation
  • Physical or psychological incapability to travel to the study center and to cooperate in the investigations

About Universitätsklinikum Hamburg Eppendorf

Universitätsklinikum Hamburg-Eppendorf (UKE) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, UKE integrates state-of-the-art facilities with a multidisciplinary approach, fostering collaboration among top-tier researchers, clinicians, and healthcare professionals. The institution is dedicated to improving patient outcomes by conducting rigorous scientific investigations that address critical health challenges, ultimately contributing to the development of novel therapies and enhancing medical knowledge.

Locations

Hamburg, , Germany

Patients applied

0 patients applied

Trial Officials

Stefan Blankenberg, Professor

Principal Investigator

Universitäres Herzzentrum Hamburg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials